This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Improved fitness can mean living longer ... Staying fit or improving fitness over time should be a goal for ... (19 Nov 2019)
Fish in early childhood reduces risk of ... Children should be introduced to fish or cod liver oil early in ... (18 Nov 2019)
Teaching group work to students with autism Structured protocol for group work could increase social ... (18 Nov 2019)
Giving breast cancer patients an average ...   Doctors who give advanced breast cancer patients just one ... (12 Nov 2019)
Complementary therapies can do more harm ...   Patients with advanced breast cancer that has spread to the ... (12 Nov 2019)
×

Warning

JUser: :_load: Unable to load user with ID: 5232
Wednesday, 09 October 2019 19:38

Study Provides Insights on Statins’ Link to Lower Prostate Cancer Risk Featured

Rate this item
(0 votes)

In a study of cancer‐free men followed for a median of seven years, statin use was associated with a lower risk of developing prostate cancer.

In the Cancer Medicine study, this association was observed only when statins had been used for a relatively long duration or at a high dose, and it was more pronounced for aggressive prostate tumors.
Among 13,065 men in the study, 2,976 were diagnosed with prostate cancer over a follow-up of up to 22 years.

“More strictly designed clinical trial studies are needed to replicate this finding,” said Kai Wang, first author, PhD, of Harvard University.



Source: Wiley

Full bibliographic information

Wang, K, Gerke, TA, Chen, X, Prosperi, M. Association of statin use with risk of Gleason score‐specific prostate cancer: A hospital‐based cohort study. Cancer Medicine. 2019; 00: 1– 9. .

Read 167 times

Latest news

Highlights

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…